CPT1C, functioning as a rate-limiting enzyme in fatty acid oxidation, exhibits a close association with cancer cell viability, tumor progression, resistance to therapeutic agents, and cellular senescence42,43. This evidence concerns the gene CPT1C and neoplasm.